Monitoring blood sugar during vitrectomy surgery for diabetes
Part of Hormones & metabolism clinical trials.
This study uses a continuous glucose monitor (CGM), a small sensor placed under the skin, to track blood sugar levels around the time of your vitrectomy surgery. The goal is to see how often low blood sugar (hypoglycemia) happens during this period, which could help improve care for people with diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years of age or older.
- You have been diagnosed with diabetes.
- You are scheduled to have vitrectomy surgery (a procedure to remove the gel-like fluid from the back of the eye).
- You are willing and able to give written permission to participate.
- You do not have a known allergy to the continuous glucose monitor (CGM) sensor, a small device placed under the skin to measure blood sugar.
- The sensor can be safely placed on your skin and valid blood sugar readings can be collected.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with an LVAD can manage their blood sugar when they use a continuous glucose monitor app on a smartphone. It may help your diabetes care team adjust treatment using more complete sugar data.
This study tests if using a continuous glucose monitor (a small sensor that checks blood sugar without finger pricks) helps people with type 2 diabetes who are on insulin and have trouble accessing care. It's for patients in the New Orleans area with Medicaid, free care, or no insurance.
This study uses continuous glucose monitors (CGMs), small devices that track blood sugar levels, in people having weight-loss (metabolic) surgery. It aims to understand how blood sugar changes after surgery and may help improve care.
This study is testing a small wearable sensor (continuous glucose monitor) to track blood sugar levels during heart surgery that uses a heart-lung machine. The goal is to see if it works well in that setting, which could improve how doctors manage your sugar levels during surgery.
This trial tests how well continuous glucose monitors (CGMs) work during surgery and hospital stays in young people with type 1 diabetes. It aims to make sure these devices give accurate readings when they are most needed.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.